Mr. Lee serves as the Chief Executive Officer of FirstVitals Inc, bringing over 35 years of executive leadership experience in healthcare services as a serial entrepreneur. As CEO, he is responsible for the overall strategic direction, operations, and financial performance of the company, driving its vision to become the leading provider of accessible, personalized, and innovative healthcare services, transforming the way individuals manage their health and well-being. Its mission is to empower individuals with the tools and support they need to proactively manage their health through convenient testing, personalized treatment, and continuous care.

Mr. Lee has a proven track record in innovative healthcare services development, corporate strategy, and clinical laboratory services. Under Mr. Lee’s FirstVitals leadership, he aims to be the market leader for an FDA-cleared at-home rapid lab testing for the monitoring and management of ongoing health conditions. He is an early pioneer in remote patient monitoring for diabetes care management, having received CMS Healthcare Innovation Award in 2012. Today, Medicare reimburses providers for non-face-to-face remote patient monitoring services.

Prior to forming FirstVitals Inc., Mr. Lee held a senior leadership role at Pearsanta Inc as its CEO where he successfully led the acquisition of an advanced clinical laboratory focused on liquid biopsy for early cancer screening for endometriosis and prostate cancer for $25MM.

Mr. Lee was issued U.S. Patent No. 60/373,903 that was acquired by VISA, USA, Inc for the processing of HIPAA compliant 835 EFT payments from insurance companies/health plans to healthcare providers.

Susan Kim van Dongen has 28 years of international executive leadership experience in managing all phases of companies including building financial operations infrastructure and effective finance and accounting teams. Leading financing, financial and SEC reporting, and managing audits, FP&A. Susan has been the strategic partner to many CEOs and executive teams for rapidly growing Private companies as well as public companies. She has overseen tax strategies, international expansions, IPOs and mergers and acquisitions.

Susan was formerly CFO of US Medical and Healthcare enterprise, CFO of MicroPicture and Visage Imaging in Germany, CFO of TomTom B.V., and Management Consulting holding Company in the Netherlands with international subsidiaries in Germany and Sweden, and CFO of Ultiverse Technologies Inc., Director of FP&A of Interleaf Inc.

A graduate of Philadelphia College of Osteopathic Medicine, Dr. Katany completed her residency in Family Medicine at the Medical College of Virginia/VCU in 1997. Her passion for continuing education and addressing root causes drove her to attain additional board certifications in Advanced Integrative and Functional Medicine and Metabolic Medicine through USF School of Medicine in 2010. She served as a primary care physician in the Carilion Clinic Health System for 12 years and as an adjunct professor of family medicine at UVA School of Medicine prior to founding Inspire Health, an Integrative and Regenerative medicine practice in Forest, VA where she served as CEO for many years. Wishing to bring this approach to more patients and healthcare providers, she joined the medical diagnostics industry in 2016, where she served as both the Director of Clinical Education as well as the VP of Product Development for innovative diagnostic lab companies. Dr. Katany also serves as a Medical Director for multiple health care entities and continues to share her knowledge of the systems biology approach with both patients and health care providers. With 30+ years of experience in direct medical care, Dr. Katany has not only successfully treated thousands of patients but has also developed advanced diagnostics that assist medical providers in improving patient care and outcomes.

As CCO, Mr. Voorhies drives the company’s marketing strategy, focusing on brand development, market expansion, and customer acquisition. He/ has extensive experience at the intersection of healthcare and technology, specializing in driving growth and improving the customer experience across a wide range of medical device, healthcare, and biotechnology sectors. With a strong background in business development, sales, and marketing, Anthony has successfully commercialized a broad portfolio of diagnostic tools, therapeutics, biomarkers, and FDA-cleared imaging and testing platforms. His expertise spans disease detection, software, and monitoring technologies, and he has a proven track record of scaling businesses from early-stage startups to publicly traded companies.